Biophore seeks DCGI emergency use nod for Aviptadil for treating Covid-19 Ruchika Sharma12 Jun 2021 10:15 AM ISTNew Delhi: Biophore India Pharmaceuticals has recently announced that the company has applied for DCGI emergency use approval of Aviptadil...
Use of ivermectin, hydroxychloroquine, favipiravir dropped from new COVID-19 treatment guidelines Ruchika Sharma9 Jun 2021 3:40 PM ISTNew Delhi: The Union Health Ministry on Monday dropped the use of ivermectin, hydroxychloroquine, and the anti-viral favipiravir from its COVID-19...
Glenmark PMS Study interim data supports favipiravir safety, effectiveness Ruchika Sharma9 Jun 2021 10:00 AM ISTMumbai: Pharma major, Glenmark Pharmaceuticals, has recently announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study...
Bal Pharma launches Favipiravir under brand name BALflu Ruchika Sharma25 May 2021 1:11 PM ISTBALflu has the efficacy to clear the virus faster by 28.7% and is marketed at a very affordable price of Rs. 85 per tablet, said Managing Director...
DCGI approves Bharat Parenterals Favipiravir Oral Suspension for treating Covid-19 Ruchika Sharma24 May 2021 4:19 PM ISTVadodara: Gujarat based pharmaceutical company Bharat Parenterals Ltd has recently announced that it has received a licence and authorization from the...
Plenty of Dexamethasone, Favipiravir stock with drugmakers: NPPA informs AIOCD Medical Dialogues Team23 May 2021 11:00 AM ISTNew Delhi: With details of specific medicine stock provided by the National Pharmaceutical Pricing Authority (NPPA), the chemist body, All India...
Brinton Pharma to ramp up Favipiravir production Medical Dialogues Team16 May 2021 9:45 AM ISTMumbai: To aid the country's fight against the deadly second wave of Covid-19, Pune-based drugmaker Brinton Pharmaceutical has announced that it will...
Combatting the second COVID 19 wave in India: Defining the role of Favipiravir dr. Abhimanyu Uppal12 May 2021 12:45 PM ISTAs India battles the second COVID-19 wave across all states, the healthcare system is overburdened with daily cases skyrocketing to more than 1.5 lac...
Glenmark FabiFlu knocks out top-selling Zincovit with April sales of Rs 352 crore Medical Dialogues Team11 May 2021 6:40 PM ISTMumbai: Knocking out top-selling multivitamin brand Zincovit, Glenmark Pharmaceutical's Covid-19 drug Favipiravir, marketed as FabiFlu secured the...
Vivimed Labs secures Indian Govt nod to manufacture, market Favipiravir Ruchika Sharma11 May 2021 10:30 AM ISTHyderabad: Drugmaker, Vivimed Labs Limited, has recently announced the receipt of Government of India (Director General of Health Services ) approval...
Bajaj Healthcare launches COVID drug favipiravir under brand name Favijaj in India Ruchika Sharma5 May 2021 11:50 AM ISTNew Delhi: Drug firm Bajaj Healthcare on Tuesday announced the launch of its antiviral Favipiravir tablets under the brand name ''Favijaj'' used for...
PIL seeks GST exemption for Remdesivir, Tocilizumab, Favipiravir, other COVID drugs, medical equipment Ruchika Sharma30 April 2021 12:00 PM ISTNew Delhi: A plea has been filed in the Supreme Court seeking GST exemption for Remdesivir, Tocilizumab, Favipiravir and other COVID-19 related drugs...
